advertisement

Topcon

Lindén C 23

Showing records 1 to 23 | Display all abstracts from Lindén C

79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980
78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Lindén C
Acta Ophthalmologica 2018; 96: 567-572
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Bengtsson B
Acta Ophthalmologica 2018; 96: 557-566
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Heijl A
Acta Ophthalmologica 2018; 96: 557-566
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Heijl A
Journal of Glaucoma 2018; 27: 976-980
78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Heijl A; Jóhannesson G
Acta Ophthalmologica 2018; 96: 567-572
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Johannesson G
Acta Ophthalmologica 2018; 96: 557-566
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Jóhannesson G
Journal of Glaucoma 2018; 27: 976-980
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Andersson-Geimer S
Acta Ophthalmologica 2018; 96: 557-566
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Lindén C
Journal of Glaucoma 2018; 27: 976-980
78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Aspberg J
Acta Ophthalmologica 2018; 96: 567-572
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Andersson-Geimer S
Acta Ophthalmologica 2018; 96: 557-566
78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Aspberg J; Aspberg J
Acta Ophthalmologica 2018; 96: 567-572
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Aspberg J
Acta Ophthalmologica 2018; 96: 557-566
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Andersson-Geimer S
Journal of Glaucoma 2018; 27: 976-980
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Aspberg J
Acta Ophthalmologica 2018; 96: 557-566
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Andersson-Geimer S
Journal of Glaucoma 2018; 27: 976-980
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Aspberg J
Acta Ophthalmologica 2018; 96: 557-566
78343 Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study
Andersson Geimer S; Bengtsson B
Acta Ophthalmologica 2018; 96: 567-572
78383 The Glaucoma Intensive Treatment Study (GITS), a randomized clinical trial: design, methodology and baseline data
Lindén C
Acta Ophthalmologica 2018; 96: 557-566
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Bengtsson B
Journal of Glaucoma 2018; 27: 976-980

Issue 20-1

Change Issue


advertisement

Oculus